PATENT CLAIM ANALYSIS

Application Number: 15918645
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "044000"]

Abstract:
The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of a Reprogramming factor, in particular, by targeting natural antisense polynucleotides of a Reprogramming factor. The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of Reprogramming factors.

Claim (Index 1):
A synthetic, modified oligonucleotide of 10 to 30 nucleotides in length comprising at least one modification wherein the at least one modification is selected from: at least one modified sugar moiety; at least one modified internucleotide linkage; at least one modified nucleotide, and combinations thereof; wherein said oligonucleotide is an antisense compound which specifically hybridizes to and upregulates the function and/or expression of a Reprogramming factor gene in vivo or in vitro as compared to a normal control.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.59459
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13320637', '14588442', '14534323', '14814895', '14297101']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8114001756410395
- 35 USC 102 Novelty (BERT): 0.5805070791917428
- Combined Prediction Score: 0.7883108659961099
- Mean Citation Score: 468.007694
- Max Citation Score: 491.61438
- Similarity Product: 434.3563563696098

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test